Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " September 26, 2012":" October 26, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 26, 2012":" October 26, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Comparison of Two IUDs Among Cape Town HIV-positive Women
Condition: HIV
Interventions: Device: Mirena levonorgestrel IUD;   Device: Copper T-380a IUD
2 Completed Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
Condition: HIV-1 Infection
3 Active, not recruiting
Has Results
Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: E/C/F/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo;   Drug: E/C/F/TAF
4 Completed Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
5 Completed First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
6 Completed Comparison of HIV Testing Algorithms
Condition: HIV Infection
Intervention: Other: application of a confirmation test
7 Completed HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
Conditions: Hepatitis C;   HIV Infections;   COINFECTION
Interventions: Drug: boceprevir;   Drug: Ribavirin;   Drug: Peginterferon alfa-2a;   Drug: Peginterferon alfa-2b
8 Completed CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
Condition: Human Immunodeficiency Virus
Interventions: Device: Intervention Arm (computer-based CARE+ Corrections tool);   Other: Educational video on opiate overdose prevention
9 Active, not recruiting A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
Condition: Human Immunodeficiency Virus-type 1 Infection
Interventions: Drug: Rilpivirine;   Drug: Efavirenz;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine
10 Completed
Has Results
A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)
Condition: HIV Infection
Interventions: Drug: Raltegravir Film-coated Tablet;   Drug: Raltegravir Chewable Tablet;   Drug: Other Anti-Retroviral Therapy
11 Active, not recruiting Network Supported Engagement In HIV Care
Conditions: HIV;   Patient Acceptance of Health Care
Intervention: Other: Supportive Care
12 Completed Antimalarial Pharmacology in Children and Pregnant Women in Uganda
Conditions: Malaria;   HIV
13 Unknown  Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
14 Completed HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing
Condition: HIV
Intervention: Behavioral: HIV knowledge Intervention
15 Unknown  Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Conditions: Hyperlipidemia;   HIV
Interventions: Drug: Pitavastatin;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Efavirenz
16 Active, not recruiting Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
Conditions: Cryptococcal Meningitis;   HIV
Interventions: Drug: Fluconazole;   Drug: Flucytosine;   Procedure: lumbar punctures
17 Completed Observational Study of Male Circumcision Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
18 Terminated Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women
Conditions: HIV Infected Women;   Healthy Women Volunteers
Intervention: Procedure: vaginal swabs by washing and cytobrush
19 Completed Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders
Condition: HCV-HIV Co-Infection
Intervention: Drug: Asunaprevir, Daclatasvir, Ribavirin and Peginterferon alfa-2a
20 Recruiting SANKOFA Pediatric HIV Disclosure Intervention
Condition: HIV
Interventions: Behavioral: Disclosure intervention;   Behavioral: Enhanced usual care

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years